0001209191-16-104904.txt : 20160302 0001209191-16-104904.hdr.sgml : 20160302 20160302200446 ACCESSION NUMBER: 0001209191-16-104904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160218 FILED AS OF DATE: 20160302 DATE AS OF CHANGE: 20160302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powell Andrew Kenneth William CENTRAL INDEX KEY: 0001304113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 161479178 MAIL ADDRESS: STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC. STREET 2: 41 UNIVERSITY DRIVE CITY: NEWTOWN STATE: PA ZIP: 18940 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-18 0 0001011835 MEDIVATION, INC. MDVN 0001304113 Powell Andrew Kenneth William C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 SVP, General Counsel & Crp Sec Common Stock 2016-02-18 4 A 0 9300 0.00 A 38250 D Stock Option (Right to Buy) 35.77 2016-02-29 4 A 0 38530 0.00 A 2026-02-28 Common Stock 38530 38530 D Represents the grant of restricted stock units that vest 1/3 on each of March 4, 2017, March 4, 2018 and March 4, 2019. The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on February 28, 2017, and the remaining shares will vest monthly over the three years thereafter. /s/ Dominic Piscitelli, Attorney-in-fact 2016-03-02